Mazor Robotics’ (MZOR) Hold Rating Reaffirmed at Needham & Company LLC
Other research analysts also recently issued reports about the stock. Standpoint Research began coverage on shares of Mazor Robotics in a research report on Friday, July 8th. They set a buy rating and a $30.00 target price for the company. Barclays PLC upped their price objective on shares of Mazor Robotics from $16.00 to $23.00 and gave the stock an overweight rating in a research report on Thursday, July 14th. Zacks Investment Research downgraded shares of Mazor Robotics from a buy rating to a hold rating in a research report on Wednesday, September 14th. Finally, B. Riley began coverage on shares of Mazor Robotics in a research report on Thursday, October 6th. They issued a neutral rating and a $25.00 price objective for the company. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has an average rating of Hold and an average price target of $26.25.
Shares of Mazor Robotics (NASDAQ:MZOR) traded down 4.2941% during midday trading on Wednesday, reaching $23.5245. The company’s stock had a trading volume of 63,264 shares. The firm’s market capitalization is $509.85 million. The stock has a 50-day moving average of $23.36 and a 200 day moving average of $18.23. Mazor Robotics has a 12-month low of $8.31 and a 12-month high of $26.55.
Mazor Robotics (NASDAQ:MZOR) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. The firm had revenue of $8.30 million for the quarter, compared to analyst estimates of $8.51 million. Mazor Robotics had a negative net margin of 60.75% and a negative return on equity of 42.30%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.05) earnings per share. Equities research analysts predict that Mazor Robotics will post ($0.71) EPS for the current fiscal year.
Several institutional investors have recently bought and sold shares of the company. Cookson Peirce & Co. Inc. bought a new position in Mazor Robotics during the second quarter worth $192,000. Trellus Management Company LLC raised its stake in Mazor Robotics by 11.6% in the second quarter. Trellus Management Company LLC now owns 23,982 shares of the company’s stock worth $431,000 after buying an additional 2,500 shares during the period. Menta Capital LLC raised its stake in Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock worth $466,000 after buying an additional 16,879 shares during the period. Candriam Luxembourg S.C.A. acquired a new stake in Mazor Robotics during the second quarter worth about $1,079,000. Finally, Iguana Healthcare Management LLC raised its stake in Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock worth $1,507,000 after buying an additional 96,151 shares during the period. 18.71% of the stock is owned by hedge funds and other institutional investors.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Stock Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related stocks with our FREE daily email newsletter.